Logo image of AMZE

AMAZE HOLDINGS INC (AMZE) Stock Fundamental Analysis

USA - NYSEARCA:AMZE - US35804X2009 - Common Stock

2.038 USD
-0.07 (-3.41%)
Last: 10/6/2025, 9:21:46 PM
2.07 USD
+0.03 (+1.57%)
After Hours: 10/6/2025, 9:21:46 PM
Fundamental Rating

2

Overall AMZE gets a fundamental rating of 2 out of 10. We evaluated AMZE against 33 industry peers in the Beverages industry. AMZE has a bad profitability rating. Also its financial health evaluation is rather negative. AMZE is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

AMZE had negative earnings in the past year.
AMZE had a negative operating cash flow in the past year.
AMZE had negative earnings in each of the past 5 years.
AMZE had a negative operating cash flow in each of the past 5 years.
AMZE Yearly Net Income VS EBIT VS OCF VS FCFAMZE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 -5M -10M -15M

1.2 Ratios

AMZE's Return On Assets of -3.59% is on the low side compared to the rest of the industry. AMZE is outperformed by 81.82% of its industry peers.
AMZE's Return On Equity of -4.79% is on the low side compared to the rest of the industry. AMZE is outperformed by 78.79% of its industry peers.
Industry RankSector Rank
ROA -3.59%
ROE -4.79%
ROIC N/A
ROA(3y)-334.97%
ROA(5y)-289.36%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
AMZE Yearly ROA, ROE, ROICAMZE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 500 -500 1K 1.5K

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for AMZE so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
AMZE Yearly Profit, Operating, Gross MarginsAMZE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 -200 -400 -600 -800 -1K

1

2. Health

2.1 Basic Checks

AMZE does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for AMZE has been increased compared to 1 year ago.
Compared to 5 years ago, AMZE has more shares outstanding
AMZE has a worse debt/assets ratio than last year.
AMZE Yearly Shares OutstandingAMZE Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 200K 400K 600K
AMZE Yearly Total Debt VS Total AssetsAMZE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 5M 10M 15M

2.2 Solvency

AMZE has an Altman-Z score of -0.52. This is a bad value and indicates that AMZE is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of -0.52, AMZE is not doing good in the industry: 78.79% of the companies in the same industry are doing better.
A Debt/Equity ratio of 0.06 indicates that AMZE is not too dependend on debt financing.
AMZE has a Debt to Equity ratio of 0.06. This is amongst the best in the industry. AMZE outperforms 81.82% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF N/A
Altman-Z -0.52
ROIC/WACCN/A
WACC8.77%
AMZE Yearly LT Debt VS Equity VS FCFAMZE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 10M -10M

2.3 Liquidity

AMZE has a Current Ratio of 0.07. This is a bad value and indicates that AMZE is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of AMZE (0.07) is worse than 93.94% of its industry peers.
AMZE has a Quick Ratio of 0.07. This is a bad value and indicates that AMZE is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.06, AMZE is not doing good in the industry: 90.91% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.07
Quick Ratio 0.06
AMZE Yearly Current Assets VS Current LiabilitesAMZE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 5M 10M 15M

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 64.07% over the past year.
The Revenue for AMZE has decreased by -83.27% in the past year. This is quite bad
AMZE shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -43.97% yearly.
EPS 1Y (TTM)64.07%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-65.85%
Revenue 1Y (TTM)-83.27%
Revenue growth 3Y-43.97%
Revenue growth 5YN/A
Sales Q2Q%-42.45%

3.2 Future

Based on estimates for the next years, AMZE will show a very strong growth in Earnings Per Share. The EPS will grow by 47.24% on average per year.
Based on estimates for the next years, AMZE will show a very strong growth in Revenue. The Revenue will grow by 1071.47% on average per year.
EPS Next Y108.53%
EPS Next 2Y47.24%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year6740.86%
Revenue Next 2Y1071.47%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
AMZE Yearly Revenue VS EstimatesAMZE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 10M 20M 30M 40M
AMZE Yearly EPS VS EstimatesAMZE Yearly EPS VS EstimatesYearly EPS VS Estimates 2025 2026 0.2 0.4 0.6

4

4. Valuation

4.1 Price/Earnings Ratio

AMZE reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
A Price/Forward Earnings ratio of 3.17 indicates a rather cheap valuation of AMZE.
Based on the Price/Forward Earnings ratio, AMZE is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
When comparing the Price/Forward Earnings ratio of AMZE to the average of the S&P500 Index (23.36), we can say AMZE is valued rather cheaply.
Industry RankSector Rank
PE N/A
Fwd PE 3.17
AMZE Price Earnings VS Forward Price EarningsAMZE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
AMZE Per share dataAMZE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10

4.3 Compensation for Growth

AMZE's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
AMZE's earnings are expected to grow with 47.24% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y47.24%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

AMZE does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

AMAZE HOLDINGS INC

NYSEARCA:AMZE (10/6/2025, 9:21:46 PM)

After market: 2.07 +0.03 (+1.57%)

2.038

-0.07 (-3.41%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryBeverages
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners1.22%
Inst Owner Change0%
Ins Owners8.19%
Ins Owner Change100%
Market Cap12.92M
AnalystsN/A
Price TargetN/A
Short Float %1.56%
Short Ratio0.91
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 3.17
P/S 50.73
P/FCF N/A
P/OCF N/A
P/B 0.17
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-5.01
EYN/A
EPS(NY)0.64
Fwd EY31.53%
FCF(TTM)-0.47
FCFYN/A
OCF(TTM)-0.47
OCFYN/A
SpS0.04
BVpS11.82
TBVpS-3.65
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -3.59%
ROE -4.79%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-334.97%
ROA(5y)-289.36%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.07
Quick Ratio 0.06
Altman-Z -0.52
F-Score4
WACC8.77%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)64.07%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-65.85%
EPS Next Y108.53%
EPS Next 2Y47.24%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-83.27%
Revenue growth 3Y-43.97%
Revenue growth 5YN/A
Sales Q2Q%-42.45%
Revenue Next Year6740.86%
Revenue Next 2Y1071.47%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y59.69%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year228.52%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y73.26%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y73.26%
OCF growth 3YN/A
OCF growth 5YN/A